Multinational pharmaceutical company conducts independent investigation of whistleblower allegations pursuant to contract audit rights
Client(s) Multinational pharmaceutical company
On behalf of a privately-owned multinational pharmaceutical company, Jones Day conducted an independent investigation of alleged misconduct and possible Foreign Corrupt Practices Act (FCPA) violations in Guatemala, Panama and Mexico. Jones Day successfully collaborated with the company's U.S. distribution partner to clear the company of misconduct while simultaneously protecting its intellectual property and business-sensitive data.